Investors looking for stocks in the Medical - Products sector might want to consider either Prestige Consumer Healthcare (PBH) or Abbott (ABT). But which of these two stocks offers value investors a b
Prestige Consumer Healthcare benefits from e-commerce momentum, acquisitions and solid solvency, even as inflation and tariff costs pose near-term risks.
Prestige Consumer Healthcare (PBH) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Investors interested in stocks from the Medical - Products sector have probably already heard of Prestige Consumer Healthcare (PBH) and Abbott (ABT). But which of these two companies is the best optio
Premium Brands Holdings Co. (TSE: PBH - Get Free Report) has been assigned an average recommendation of "Buy" from the ten brokerages that are presently covering the firm, MarketBeat.com reports. Two
Ariel Investments LLC lessened its holdings in shares of Prestige Consumer Healthcare Inc. (NYSE: PBH) by 12.6% in the second quarter, according to the company in its most recent disclosure with the S
The consensus price target hints at a 26.1% upside potential for Prestige Consumer Healthcare (PBH). While empirical research shows that this sought-after metric is hardly effective, an upward trend i
Fisher Asset Management LLC trimmed its holdings in shares of Prestige Consumer Healthcare Inc. (NYSE: PBH) by 6.8% in the undefined quarter, according to the company in its most recent disclosure wit
Investors interested in Medical - Products stocks are likely familiar with Prestige Consumer Healthcare (PBH) and Abbott (ABT). But which of these two stocks is more attractive to value investors?
Premium Brands Holdings Corporation ( PBH:CA ) Q3 2025 Earnings Call November 10, 2025 1:30 PM EST Company Participants George Paleologou - President, CEO & Director Will Kalutycz - Chief Financial Of
Prestige Consumer Healthcare Inc. ( PBH ) Q2 2026 Earnings Call November 6, 2025 8:30 AM EST Company Participants Philip Terpolilli - Director of Investor Relations Ron Lombardi - Chairman, President
Prestige Consumer Healthcare (PBH) came out with quarterly earnings of $1.07 per share, beating the Zacks Consensus Estimate of $0.97 per share. This compares to earnings of $1.09 per share a year ago
TARRYTOWN, N.Y., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its second quarter and first six months ended September 30, 2025.
Prestige Consumer Healthcare (PBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Value Plus Strategy gained 8.50% in the third quarter, compared with the 12.60% gain for the Russell 2000® Value Index. Brady's core business is identification solutions for commercial products,
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE